Concepedia

Shruti Daga

SD

Statistics

Publications

12

Citations

2.1K

H-Index

12

Active since

2009

Affiliations

GlaxoSmithKline (United States)(Current)

University of Edinburgh

GlaxoSmithKline (United Kingdom)

Medical University of Graz

Center For Biomarker Research In Medicine

Shruti Daga is an author at GlaxoSmithKline (United States) specializing in medicine, cardiovascular pharmacotherapy, and pharmacotherapy.

Publications per year

2009–2020

12

Publications

12

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

, , +17

Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers

Sowmya Venkatasubramanian, Radzi M Noh, Shruti Daga et al. · Journal of the American Heart Association · 2013 · 91 citations · Full text

, , +13

P‐selectin antagonism reduces thrombus formation in humans

Raj Chelliah, Andrew Lucking, Laura Tattersall et al. · Journal of Thrombosis and Haemostasis · 2009 · 37 citations · Full text

, , +12

Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence

Owen Clark, Shruti Daga, Andrew W. Stoker · Cancer Letters · 2012 · 36 citations

, , +15

High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34‐positive AML

Shruti Daga, Angelika Rosenberger, Franz Quehenberger et al. · Cancer Medicine · 2019 · 35 citations · Full text

, , +17

1–5 of 12